Suppr超能文献

[心房利钠肽。II. 病理生理学及可能的临床意义。综述]

[Atrial natriuretic peptide. II. Pathophysiology and possible clinical significance. Review].

作者信息

Vollmar A M

机构信息

Institut für Pharmakologie, Toxikologie und Pharmazie der Tierärztlichen Fakultät, Ludwig-Maximilians-Universität München.

出版信息

Tierarztl Prax. 1990 Aug;18(4):319-22.

PMID:2145657
Abstract

The heart atrium, as well as under certain pathophysiological conditions the ventricle, synthesize and release ANP. Exerting natriuretic, diuretic and vasorelaxant effects, this peptide plays an important role in the body's blood volume and blood pressure homeostasis. Whereas the pharmacological actions of ANP have been quite convincingly demonstrated, its physiological and pathophysiological role is less well defined. ANP plasma levels tend to be increased in diseases with salt and water retention, such as essential hypertension, congestive heart failure, renal failure or liver cirrhosis. With regard to its hemodynamic effects, ANP seems to be beneficial in patients with hypertension. ANP appears to have little therapeutic potential as a diuretic in patients with congestive heart failure and liver cirrhosis, possibly due to the decreased renal responsiveness to ANP in these diseases. However, ANP might to be a valuable therapeutic agent in acute renal failure.

摘要

心房以及在某些病理生理条件下的心室,均可合成并释放心钠肽(ANP)。该肽具有利钠、利尿和血管舒张作用,在机体血容量和血压稳态中发挥重要作用。尽管心钠肽的药理作用已得到相当确凿的证实,但其生理和病理生理作用尚不太明确。在伴有水钠潴留的疾病中,如原发性高血压、充血性心力衰竭、肾衰竭或肝硬化,血浆心钠肽水平往往会升高。就其血流动力学效应而言,心钠肽似乎对高血压患者有益。在心衰和肝硬化患者中,心钠肽作为利尿剂的治疗潜力似乎不大,这可能是由于这些疾病中肾脏对心钠肽的反应性降低所致。然而,心钠肽在急性肾衰竭中可能是一种有价值的治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验